The placenta acts as a major organ for hematopoiesis. It is believed that placental hematopoietic stem and progenitor cells (HSPCs) migrate to the fetal liver to ensure optimum hematopoiesis in the developing embryo. The labyrinth vasculature in a mid-gestation mouse placenta provides a niche for the definitive hematopoietic stem cell (HSC) generation and expansion. It has been proposed that these processes are regulated by a host of paracrine factors secreted by trophoblast giant cells (TGCs) at the maternal-fetal interface. However, the molecular mechanism by which the TGCs regulate the hematoendothelial niche in a developing placenta is yet to be defined. Using a TGC-specific Gata2 and Gata3 double knockout mouse model, we
Introduction
Trophoblast cells of the placenta establish a vascular connection between the mother and the fetus and express hormones that are essential for the successful progression of pregnancy.
Placenta also acts as one of the major organs for hematopoietic stem cell (HSC) generation, and the mid-gestation mouse placenta plays a significant role in the HSC development where it provides a temporary niche for definitive HSC pool. Defective development of placental hematopoiesis and vasculogenesis leads to serious pathological conditions such as preeclampsia and fetal growth retardation (FGR). These disorders result in pregnancy-related complications, maternal, prenatal & neonatal mortality, and affect ~2-8% of pregnant women worldwide (1, 2). The pathogenesis in preeclamptic patients is believed to be a response of vasculature to abnormal placentation (3) . Thus, to define therapeutic modalities against these pregnancy-associated disorders, it is crucial to understand the molecular mechanisms that are associated with the proper development of placental hematopoiesis and vasculogenesis.
Trophoblast cell differentiation in the placenta involves mechanisms by which secreted paracrine factors within the placenta, and from the fetus & the mother regulate embryonic and extraembryonic development (4) . Embryonic hematopoietic sites are characterized by the interlinked developments of the vascular and hematopoietic systems. Several studies have shown that the hemangioblasts and hemogenic endothelium act as the presumptive precursors to emerging hematopoietic cells (5) . It has been indicated that the definitive hematopoiesis is autonomously initiated in the placenta which subsequently generates HSCs from hemogenic endothelium and provides a niche for expansion of aorta-derived HSCs (6, 7) . On the other hand, secreted pro-angiogenic factor, like Placental Growth Factor (Pgf), a member of the Vascular Endothelial Growth Factors (VEGF) family, and anti-angiogenic factors, like Vascular Endothelial Growth Factor receptor-1 (Flt1) and Endoglin (Eng), are expressed in the mouse placenta, indicating autocrine or paracrine actions (8, 9) . How these signaling mechanisms influence the development of the maternal-fetal interface are poorly understood.
Several studies have implicated the role of the GATA family of transcription factors in the development of HSCs in other organs, and previously we have shown that GATA2 and GATA3 are involved in the trophoblast development and differentiation (10) (11) (12) (13) . They are implicated in the regulation of the expression of several trophoblast-specific genes, including prolactin hormone Placental lactogen I (Prl3d1, Pl1) and the angiogenic factor Proliferin (Prl2c2, Plf), which play an essential role in the neovascularization of the placenta (14, 15) . Recently we demonstrated that simultaneous knockout of both Gata2 and Gata3 in trophoblast lineage severely affects placental development (16) . Also, the double gene knock-out resulted in significant developmental defects in the embryo proper leading to very early embryonic lethality (16) . These developmental defects were accompanied by severe blood loss in the placenta, yolk sac and the embryo proper.
Moreover, we established dual conditional Gata2 and Gata3 knockout trophoblast stem cells and used ChIP-Seq and RNA-Seq analyses to define independent and shared global targets of GATA2 and GATA3. We found that several pathways associated with the embryonic hematopoiesis and angiogenesis are targets for both transcription factors.
However, very little is known about how these two master regulators operate in a spatiotemporal manner during placental development and dictate key placental processes like hematopoiesis and angiogenesis.
Results

GATA mutation in the trophoblast giant cell layer in mouse embryos display embryonic and extraembryonic hematopoietic defects
Our previous studies have shown that the loss of GATA factors in the trophoblast lineage cells results in the gross phenotypic abnormality in the placenta and the embryo proper in a mouse model (16) . The placenta contains distinct layers of differentiated trophoblast cells, each having specialized functions to support a pregnancy. These include Trophoblast Giant Cells (TGC), spongiotrophoblasts (SpT), glycogen trophoblasts, and labyrinthine trophoblasts. Each subclass is characterized by its unique gene expression signatures (17) . Thus, it is imperative to analyze how GATA factors act in the different subclasses of trophoblast cells in the context of placental development and function. As TGCs have been reported to express both GATA2 and GATA3, we chose to knockout Gata2 and Gata3 together in the TGCs (14) . Placental TGCs are marked by the expression of two prolactin family of proteins Prl2c2 (Plf) and Prl3d1 (Pl1). Although Plf expression starts at E6.5 in the parietal TGCs, in the latter part of gestation Plf is also expressed in the spiral artery associated TGCs and canal space associated TGCs (18) . Moreover, Plf is expressed in a small population of spongiotrophoblast cells (18) . On the other hand, Pl1 expression is restricted to the parietal TGCs only (18) . Thus, to restrict GATA deletion exclusively to the parietal TGCs, we used a Prl3d1 tm1(cre)Gle (Pl1 Cre ) mouse model, where Cre recombinase is selectively expressed in the Pl1 expressing cells, and established a conditional GATA knockout (19, 20) . These mice were used to selectively knockout both Gata2 and Gata3 in the parietal trophoblast giant cells.
We also developed a murine model in which the trophoblast giant cell layers were fluorescently labeled. We used Gt(ROSA)26Sor tm4(ACTB-tdTomato,-EGFP)Luo /J, (also known as mT/mG) mouse model, which possesses loxP flanked membrane-targeted tdTomato (mT) cassette and expresses strong red fluorescence in all tissues (21) . Upon breeding with Cre recombinase expressing mice, the resulting offsprings have the mT cassette deleted in the cre expressing tissue(s), allowing expression of the membrane-targeted EGFP (mG) cassette located in-frame immediately downstream ( Fig. 1A) .
Microscopic analyses of the conceptuses and their cryosections from a cross between Pl1 Cre male and mT/mG female confirmed the selective GFP fluorescence in the parietal TGC layers only ( Fig. 1B) . Previous studies have shown that the major expansion of the hematopoietic stem cell (HSC) population in the mouse placenta takes place between E11.5 and E13.5 (22) . Thus
Gata2 f/f ;Gata3 f/f ;Pl1 Cre males were crossed to Gata2 f/f ;Gata3 f/f females and the embryos were analyzed between E10.5 and E13.5 (Fig. C) . Resulting phenotypic abnormalities were observed mostly at E12.5 and E13.5. For all subsequent analyses, E12.5 and E13.5 conceptuses were chosen.
Two major groups of embryos with distinct phenotypic abnormalities were observed in the Pl1 Cre positive embryos ( Fig. 1D, E) . One group showed very early embryonic death and was associated with tiny fetal and placental tissues ( Fig. 1E, F) . The other group showed significant growth retardation, developmental defects, and blood loss in the embryo proper, while their placentae showed significant anomalies in size and thickness and were associated with apparent blood loss ( Fig. 1E, G) . These placentae also showed hemorrhage and apparent loss of vasculature ( Fig.   1G ). These defects were most prominent at E12.5 and E13.5 ( Table 1) . Non-Cre embryos from the same littermates were treated as controls ( Fig. 1E, G) . Along with these gross abnormalities, significant alterations in the placental architecture were observed in the GATA-Pl1 KO samples.
A marked increase in the junctional zone (marked by the spongiotrophoblast/ glycogen trophoblast marker Tpbpa) ( Fig. 1H, I) was observed compared to the control.
Interestingly, the fetal liver in the GATA-Pl1 KO embryos showed blood loss ( Fig. 1G) . It is speculated that along with the HSPCs from the yolk sac, the placental HSPCs migrate to and seeds fetal liver for hematopoiesis (23) . Our results bolster this hypothesis and indicate that the placenta acts as a major contributing partner to the fetal liver hematopoiesis.
A small percentage of Gata2 f/f ;Gata3 f/f ;Pl1 Cre embryos escaped the fate and resulted in live-born pups ( Table 1) . These animals showed no apparent phenotypic abnormalities, were healthy and fertile. Genotyping results showed no Cre-mediated excision activities in different tissues (data not shown). For the embryo analyses, we used these males for mating with non-Cre females to restrict the effect of GATA deletion exclusively in the fetal tissue.
Thus, our study showed that the GATA factor-loss in the parietal TGCs of the placenta was sufficient to significantly impair embryonic and extraembryonic growth and also resulted in blood loss and vasculature defects.
GATA factor functions in parietal giant cells regulate trophoblast progenitor developments
Some of the critical tasks of TGCs are the secretion of autocrine and paracrine factors that are involved in the trophoblast outgrowth and placental development process (24) (25) (26) . Genetic knockout models targeting TGC specific genes have been shown to affect lineage-specific trophoblast differentiation and thereby results in abnormal development of the placenta (20, 24, 27, 28) . To analyze the effect of GATA deletion in the TGCs, we performed Single-cell RNA-Sequencing (scRNA-seq) analyses of E13.5 placenta from a pregnant Gata2 f/f ;Gata3 f/f female crossed with Gata2 f/f ;Gata3 f/f ;Pl1 Cre male. Two individual GATA-Pl1 KO placentae and two individual control littermate placentae were used for the sequencing. The genotypes were confirmed by PCR using tissue from the embryo proper. The knockout placentae were chosen based on their apparent growth defects and blood loss phenotypes ( Fig. 1G) .
T-distributed Stochastic Neighbor Embedding (t-SNE) plot of the aggregated hierarchical clustering of the four samples revealed 33 distinct clusters ( Fig. 2A) . The clustering of both the control samples showed significant similarity to each other, while significant clustering similarities were observed in both the knock-out samples, indicating a high degree of homology between the placenta of same genotypes (Sup. Fig. S1A) . A comparison between the control sample and the knockout sample populations showed significant gain in subpopulations defined by individual clusters. While the control samples showed considerable enrichment in clusters 2, 5, 6, 10, 17, 18 and 28, the knockout samples showed enrichment in clusters 1, 3, 7, 9, 14, 20, 21, 23, 29, 30, and 32 ( Fig. 2B) . Trophoblast cell population was identified using keratin 8 (Krt8) expression ( Fig.   2C ). Using significant gene expression (p<=0.05) profile of different trophoblast specific genes with a log 2-fold expression of more than zero, we matched major trophoblast gene markers of a mouse placenta with their corresponding clusters (Sup . Table 1 ). While the TGC markers Prl3d1 (Pl1) and Prl2c2 (Plf) showed mostly similar expression pattern (clusters 11, 22, 33, 2, 1 and 33, 22, 25, 11, 1 respectively), the spongiotrophoblast marker Trophoblast-specific protein alpha (Tpbpa) showed association with clusters 22, 33, 11, 1 and 9 with highest expression in the cluster 22 ( Fig. 2D , Sup. Table 1 ). Cathepsin Q (Ctsq), a marker for sinusoidal trophoblast giant cells, which line the labyrinth sinusoids and constitute part of the interhemal membrane, showed significant expression associated with cluster 6 ( Fig. 2D , Sup. Table 1) (31) . Epithelial cell adhesion molecule (Epcam), which marks the chorion derived labyrinth progenitors, showed similar expression patterns (clusters 16, 27) in both the control and the KO populations ( Fig. 2D , Sup. Table 1) . Interestingly, prolactin family member Prl3b1, which marks both sinusoidal TGCs and parietal TGCs, showed an identical cluster association with Tpbpa (Sup. Fig. S1B , Sup. which confirmed an earlier report that Gcm1 expression reduces significantly after E9.5 (Sup. (29, 30) . We also observed significant expression of Caudal type homeobox 2 (Cdx2), a trophoblast stem cell marker, in clusters 20, 26 and 8 (Sup. Fig. S1B , Sup. Table 1 ). Comparative analyses of the control and the KO samples showed significant alterations in these identified trophoblast subpopulations. While Prl3d1+ parietal TGCs did not show much change, we observed a marked decrease in the Prl2c2+ TGC population in the GATA-Pl1 KO placentae compared to the controls ( Fig. 2E) . Also, Tpbpa+ spongiotrophoblast/ glycogen trophoblast population, as well as Epcam Hi + labyrinth progenitor population, Prl3b1+ secondary giant cells, all showed marked increase in the KO samples, ( Fig. 2E, Sup. Fig. S1B) . Surprisingly, our data also revealed a considerable increase in the Cdx2+ cell population in the GATA-Pl1 KO placentae ( Fig. 2E, Sup. Fig. S1B ). However, not all of these cells showed simultaneous expression of other trophoblast stem cell markers E74-like factor 5 (Elf5), Eomesodermin (Eomes), Estrogen related receptor, beta (Esrrb). A fraction of the Cdx2 expressing cells showed co-expression of Elf5, while another fraction was positive for Esrrb. Interestingly, both these fractions were also found to be co-expressing labyrinth marker Epcam and Dlx3, indicating the role of intermediate progenitor state in the developing labyrinth. We also noticed a significant decrease in the Ctsq positive trophoblast cells in the knockout placentae ( Fig. 2D, E) .
Together, these findings revealed that the parietal TGC-specific loss of GATA factors skews the trophoblast differentiation process and thereby alters the distribution of trophoblast subpopulations in the developing placenta and affects gross placental architecture. Remarkably, these data also indicate a novel method whereby the parietal TGC-specific paracrine signaling dictates the differentiation of the different trophoblast progenitors and regulates the development of distinct placental layers.
Loss of GATA factors disrupts hematopoietic-endothelial cell lineage segregation and affects fetal hematopoiesis
The placenta is one of the major sites for de novo hematopoiesis in an embryo (22) . Not only does it support the expansion of the nascent HSC population, but it also protects the HSCs from premature differentiation cues. As the placenta is a known source of a plethora of cytokines and hormones, it is essential to define how these signals promote hematopoietic development in the embryo. Several studies have implicated primary and secondary trophoblast giant cells in secreting paracrine and endocrine factors (31) . These include prolactin/ placental lactogen class of hormones (32) , interferon (25) , vasodilators (33) , and anticoagulants (34) . Along with them, TGCs have also been shown to secrete angiogenic factors (27, 35, 36) . A hallmark of fetal hematopoiesis is the interrelated development of vascular and hematopoietic systems where hemogenic endothelium and hemangioblasts serve as the precursors to the hematopoietic stem cell populations (37) .
We used Ingenuity Pathway Analysis (IPA) to compare the physiological functions of the Prl3d1+ cells between the control and the KO samples using scRNA-seq data. Our results indicated that major physiological functions related to the hematopoiesis and angiogenesis were downregulated in the Prl3d1+ cells in the GATA-Pl1 KO samples (Sup. Fig. S2 ). These results also bolstered our findings that the GATA factor loss in the parietal TGCs adversely affected embryonic hematopoiesis and angiogenesis.
Placental HSCs are localized in the labyrinth and umbilical blood vessels (38) and are characterized by the surface markers CD34, KIT, and Sca-1 (Ly6A) (39) . We used our scRNAseq data to identify the hematopoietic stem cells in the control compared to the KO samples. We found that the major populations of the HSCs which express both KIT and CD34 are localized mostly in the clusters 15 and 17 (Fig. 3A, B ). Further analyses of these two clusters revealed that out of these two populations, only the cells in the cluster 15express endothelial cell marker Kdr.
These suggest that the cells in the cluster 17 represent true hematopoietic stem cell lineage in a developing placenta.
Multiple studies have shown that the embryonic hematopoiesis is intricately connected to the vascular development where hemogenic endothelium, a part of the vascular endothelial cells gives rise to the definitive hematopoietic precursors during mammalian development (40) (41) (42) (43) (44) .
Thus, the genetic signature of the cells in cluster 17, which is unique to the knockout samples, indicates a hematoendothelial cell population that still retains the HSC lineage markers (Fig. 3B) .
This cell population was also found to express hematoendothelial markers Cdh5, Icam2, Cd40, confirming the bipotent nature of these cells (45) (46) (47) . As a high expression of the arterial-specific marker Delta-like, 4 (Dll4) is essential for the segregation of the endothelial lineage from the hematopoietic lineage (48, 49) , we looked at the Dll4 expression in this subset, and found that this cluster expresses a high level of Dll4. Thus, the loss of GATA factors in the parietal TGCs skews the hematopoietic-endothelial lineage specification in a developing placenta and leads to the arrest of hematoendothelial progenitor population compared to the control.
We further analyzed these cells for the expression of Sca-1, another HSC marker, and Cd45, a differentiated hematopoietic marker, and found that while the small HSC population in cluster 17
express Sca-1, they do not express Cd45 (Fig. 3C, D) , confirming their undifferentiated HSC identity. Further analysis Quantitative analysis showed a severe reduction in the HSC population in the GATA-Pl1 KO placentae compared to the control (Fig. 3E) .
As the vascular labyrinth of a developing placenta harbors HSC population, we also tested the loss of the HSC population in the placental labyrinth by immunohistochemistry. E12.5 and E13.5 placental sections were stained with an anti-KIT antibody, while the placental layers were costained using an anti-pan-cytokeratin antibody. The control placenta showed several clusters of KIT + cells in the labyrinth, while consistent with our scRNA-seq data, the KO placenta showed severe loss of KIT + cell population (Fig. 4A) .
We also used three surface markers CD34, KIT and Sca-1 (Ly6A), which together define the placental HSCs, as the determinant for the long-term reconstituting (LTR) HSC population and screened them against the population expressing CD45, which is a pan-hematopoietic surface marker and appear on the more mature HSCs (50) , and a cocktail of lineage markers (Lin). We used placental single-cell suspension from control and GATA-Pl1 KO placentae and subjected them to flow analysis where KIT + CD34 + Ly6A/E + cells were selected against Lin -CD45expressing cells. In the GATA-Pl1 KO placental samples, the Lin -CD45 -KIT + CD34 + Ly6A/E + cell population was significantly reduced compared to the control (Fig. 4B) . Compared to the total number of cells, the percentage of the HSC population in the KO placenta (0.001±0.000) was significantly lower than that in the control population (0.006±0.001) ( Fig. 4C) .
Next, we evaluated the differentiation potential of the GATA-Pl1 KO placental HSCs by using colony-forming assay. Placental single-cell suspension from the control and GATA-Pl1 KO placentae were plated on methylcellulose medium containing a cocktail of Stem Cell Factor (SCF), IL-3, IL-6, and Erythropoietin. The placental samples gave rise to mostly granulocyte and mixed lineage erythroid, macrophage colonies ( Fig. Sup. S3 ). We observed a significant reduction in the number of colonies generated from the GATA-Pl1 KO placentae compared to the control (Fig. 4D, E) .
Collectively these data prove that the GATA factor KO in the trophoblast giant cells negatively affects hematopoiesis in the placenta and results in the apparent blood loss phenotype. The loss of the HSC population was also accompanied by the incomplete segregation of the hematopoietic and endothelial lineage, indicating a loss of signaling network that balances and fine-tunes the hematopoietic versus endothelial cell lineage development in the placenta.
TGC-specific loss of GATA factors affects embryonic vasculature development
Embryonic hematopoiesis and angiogenesis are tightly linked. Hemogenic endothelium in the vascular labyrinth gives rise to both the endothelial cell population as well as the hematopoietic cell population. As our study revealed a defective hematopoietic and endothelial lineage segregation due to TGC-specific GATA factor loss, we used our GATA-Pl1 KO placentae model to test placental angiogenesis. Anti-CD31 (PECAM-1) antibody, which marks early and mature endothelial cells, was used to stain the vasculature in the placental sections at E13.5. Compared to the control samples, the KO placentae showed gross disruption of the blood vessel architecture in the labyrinth. The KO placental samples displayed defective branching, unlike the complex placental vasculature branching observed in the control samples ( Fig. 5A, B) .
Embryonic angiogenesis relies on a delicate balance of several key pro-angiogenic and antiangiogenic factors (51) (52) (53) (54) . Among them, pro-angiogenic placental growth factor (Pgf), antiangiogenic factors soluble TGF-β1 receptor Endoglin (Eng), and soluble Vascular Endothelial Growth Factor (VEGF) receptor Flt1 (Fflt1) have been shown to play essential roles in the placental vascularization and angiogenesis (55) (56) (57) (58) . We tested our knockout samples for the mRNA expression of these genes. Our results revealed significant downregulation of proangiogenic Pgf while significant upregulation of antiangiogenic Eng, Flt1 and its soluble isoform sFlt1 was observed in the GATA-Pl1 KO placentae compared to the control (Fig. 5C) .
To functionally test this increase in the sFlt1 level, we performed matrigel based vascular tube formation assays using Human Uterine Microvascular Endothelial Cells (HUtMEC). Harvested conditioned media from the Gata2/Gata3 double knockout (GATA DKO) trophoblast stem cells and control trophoblast stem cells described in our earlier study (16) were added to the assays individually. Interestingly, HUtMECs in the presence of the conditioned media from the control trophoblast stem cells, readily formed tubular structure while they failed to do so in the presence of conditioned media from GATA DKO trophoblast stem cells (Fig. 5D) .
These findings indicate that the loss of GATA factors in the TGC layer results in the disruption of the delicate balance between the secreted angiogenic and antiangiogenic factors, which in turn prevent proper development of the labyrinth vasculature in the placenta.
Multiple studies have implicated HIF family of proteins, HIF1a, and HIF2a, in the trophoblast differentiation process, and they have been shown to promote spongiotrophoblast differentiation in the placental development (59, 60) . HIF family of proteins are also intricately connected to angiogenesis. On the one hand, they have been shown to be the master regulators of angiogenesis, while on the other hand, defective vasculature leads to hypoxia which in turn stabilizes HIF1a (61, 62) . Since TGC-specific GATA factor-loss resulted in a vasculature defect,
we designed experiments to study the role of HIF1a in the knockout placenta. HIF1a immunostaining of the cryosectioned implantation sites showed significantly stronger HIF1a expression in the GATA Pl1-KO placenta compared to the control. Thus, the defective vasculature in the knockout embryos were associated with the upregulation and stabilization of HIF1a (Fig.   5E ).
It has been demonstrated that the HIF1a overexpression in mice leads to fetal IUGR and abnormalities in the developing placenta through the upregulation of sFlt1 (63). As we have discussed above, GATA Pl1-KO samples showed elevated expression of sFlt1, indicating a possibility that the fetal growth retardations observed in the GATA Pl1-KO embryos are regulated by this HIF1a-sFlt1 regulatory axis.
HIF1a stabilization also induces spongiotrophoblast markers Tpbpa and Ascl2 (64) and promotes spongiotrophoblast differentiation (65) . mRNA expression analyses of the knockout placenta revealed a significant increase in both Tpbpa and Ascl2 level (Fig. 5F) , leaving scope for further evaluation of the HIF1a feedback loop in GATA Pl1-KO placental development.
GATA loss alters trophoblast giant cell-mediated paracrine signaling
TGCs are known to be a major source of autocrine and paracrine factors in the placenta (18, 66) .
These factors, in turn, influence the development of the placenta as well as regulate numerous placental functions. We used our Gata2 f/f ;Gata3 f/f ;mT/mG mouse model to analyze the paracrine signaling in the light of GATA loss in the TGCs. As described above, E12.5 conceptuses from a cross between Gata2 f/f ;Gata3 f/f ;Pl1 Cre and Gata2 f/f ;Gata3 f/f ;mT/mG were harvested and chosen for strong GFP fluorescence indicating the presence of Pl1 Cre (Fig. 6A) . The GFP-positive cells were sorted using FACS (Fig. 6B) . Pl1 Cre ;mT/mG conceptuses were used as control. mRNA samples were prepared from these cells and were used for subsequent qPCR analyses. As TGCs are marked by the expression of Prl3d1 and Prl2c2 and it has been shown that these two factors are regulated by GATA factors (16, 67) , we tested their expression in the GATA Pl1-KO samples.
Both Prl3d1 and Prl2c2 mRNA prepared from these cells showed a significant reduction in their expression levels compared to the control (Fig. 6C ). Furthermore, we tested several endocrine and paracrine factors secreted by the TGCs that are important for hematopoiesis and angiogenesis.
Among the prolactin like protein family members secreted by the TGCs, Prl7a1, and Prl7a2 are known to regulate erythroid proliferation and differentiation as well as megakaryocyte differentiation (68, 69) . Our qPCR analyses revealed significant reductions in Prl7a2, but not in Prl7a1 expression in the TGCs from GATA Pl1-KO placentae (Fig. 6C) . These results indicate to the possibility that the loss of the HSC population in the double knockout placenta was partially due to the downregulation of Prl7a2 in the TGCs.
TGCs also secrete the hormone Adrenomedullin (Adm), a vasodilator implicated in the placental angiogenesis (70, 71) . A low level of adrenomedullin contributes to the preeclamptic human placenta (72) . We tested the level of Adm in the double knockout TGCs and found that the Adm level was significantly downregulated (Fig. 6D) .
Additionally, our analyses of the VEGF family members in the GATA Pl1-KO TGCs revealed significant upregulation of Vegfb while Vegfa showed no significant difference compared to the control (Fig. 6E) . We also observed significant upregulation of sFlt1 in the knockout samples ( Fig.   6F) . Interestingly, our scRNA-seq data revealed that along with the arrested hematoendothelial progenitor population, Tpbpa+ spongiotrophoblast cells were a significant source of sFlt1 in the knockout placenta ( Fig. 6G) , which is consistent with an earlier report (8) . Thus, our findings reveal that the loss of GATA factors influenced the level of Flt1 in the knockout placentae in two distinct ways. On the one hand, it increases the sFlt1 level in the GATA Pl1-KO TGCs while, on the other hand, it increases the number of Tpbpa+ spongiotrophoblast cells and in turn increases the sFlt1 level in the knockout placentae.
Overall, these findings implicate TGC-specific GATA2 and GATA3 to be not only critical regulators of placental development but also essential players for maintaining the delicate balance between the hematopoietic and endothelial lineage segregation in the developing placenta. Thus, we propose a model where GATA2 and GATA3 in the Prl3d1+ parietal TGCs control TGC-specific paracrine signaling and thereby directly regulates the differentiation of the hematoendothelial niche in the placental labyrinth and promotes the differentiation of the spongiotrophoblast layer ( Fig. 6H) . Upregulated sFlt1 from the GATA-null parietal giant cells, enhanced spongiotrophopblast layer and the impaired hematoendothelial niche, results in the fetal growth retardation, altered trophoblast progenitor differentiation program and defective hematopoiesis and angiogenesis. This impaired placental angiogenesis contributes to the upregulation and stabilization of HIF1a, which in turn affects the Tpbpa+ spongiotrophpblast differentiation through the alteration of sFlt1 level in a negative feedback loop manner (Fig. 6H) .
Discussion
GATA factor function in trophoblast differentiation and function has been subjected to numerous studies. Previously, we showed how GATA2 and GATA3 have overlapping functions during placental development, where the simultaneous loss of both the factors in all trophoblast cells leads to early embryonic death and placental defect with impaired hematopoiesis (13, 16) . It also revealed the loss of placenta layers, including the labyrinth region. Interestingly, the pantrophoblast-specific knock out did not show any change in the trophoblast giant cell layer at the junctional zone. So, in this study, we chose to delete GATA2 and GATA3 in the Prl3d1 expressing parietal giant cell layer of the placenta.
As the placenta is a complex tissue consisting of diverse trophoblast subtypes as well as hematopoietic and endothelial cell populations, it is of utmost importance to categorize these cellular subtypes and define cell-cell interactions at the single-cell resolution. Our Single Cell RNA-Seq data not only revealed the genetic signatures of the major trophoblast subtypes but also showed how the GATA-factor loss altered the differentiation of the progenitor population and thereby altered the distribution of cells at different placental layers. Data from our 
Materials and methods
Cell culture and reagents
Mouse trophoblast stem cells (TSCs) were cultured with FGF4, Heparin, and MEF-conditioned medium (CM) according to the protocol (73) . Gata2 and Gata3 floxed alleles were efficiently excised from Gata2 f/f ;Gata3 f/f ;UBC-cre/ERT2 (GATA DKO) TSCs by culturing the cells in the presence of tamoxifen (1 μg/ml) (16) . Conditioned media was harvested upon removal of tamoxifen and was used for subsequent experiments. 
Generation of conditional knockout mice strains
Embryo harvest and tissue isolation
Injected animals were euthanized on at desired day points, as indicated in the main text. Uterine horns and conceptuses were photographed. Conceptuses were dissected to isolate embryos, yolk sacs, and placentae. All embryos and placentae were photographed at equal magnification for comparison purposes.
Uteri containing placentation sites were dissected from pregnant female mice on E12.5 and E13.5 and frozen in dry ice-cooled heptane and stored at −80°C until used for histological analysis.
Tissues were subsequently embedded in optimum cutting temperature (OCT) (Tissue-Tek) and
were cryosectioned (10µm thick) for immunohistochemistry (IHC) studies using Leica CM-3050-S cryostat.
Placenta samples were carefully isolated, ensuring the decidual layer was peeled off. Individual samples were briefly digested in the presence of collagenase and were made into single-cell suspensions by passing them through a 40µm filter. These cell suspensions were further used for Flow analysis or FACS. Corresponding embryonic tissues were used to confirm genotypes.
For scRNA-seq, these samples were further processed using Debris Removal Solution and Dead Cell Removal Kit (Miltenyi Biotec). Red blood cell depletion from the placental suspensions were carried out using anti-Mouse Ter-119 antibody (BD Biosciences) was used. 
Flow analysis and sorting
Single Cell RNA-Sequencing and analysis
The transcriptomic profiles of mouse placental samples from two control (biological replicates) and two Gata2/Gata3 double knockout (biological replicate) specimens were obtained using the 10x Genomics Chromium Single Cell Gene Expression Solution (10xgenomics.com). The primary analysis of the scRNAseq data was performed using the 10x Genomics Cell Ranger pipeline (version 3.1.0). This pipeline performs sample de-multiplexing, barcode processing, and single cell 3' gene counting. The quality of the sequenced data was assessed using the FastQC software (76) . Sequenced reads were mapped to the mouse reference genome (mm10) using the STAR software (77) . Individual samples were aggregated using the "cellranger aggr" tool in Cell Ranger to produce a single feature-barcode matrix containing all the sample data. This process normalizes read counts from each sample, by subsampling, to have the same effective sequencing depth. The Cell Ranger software was used to perform two-dimensional PCA and t-SNE projections of cells, and k-means clustering. The 10x Genomics Loupe Cell Browser software was used to find significant genes, cell types, and substructure within the single-cell data.
Colony Formation Assay
Placenta cell suspensions were suspended in Iscove's MDM with 2% fetal bovine serum and cultured using a MethoCult GF M3434 Optimum kit (STEMCELL Technologies). 10,000 cells from each sample were plated in 35-mm culture dishes (STEMCELL Technologies) and incubated at 37°C in a humidified, 5% CO2 environment for 14 days. Colonies were observed and counted using an inverted microscope.
In Vitro Endothelial Network Assembly Assay on Matrigel
Endothelial network assembly was assayed by the formation of capillary-like structures by Human Uterine Microvascular Endothelial Cells (HUtMEC) on Matrigel (BD Biosciences). Matrigel was diluted 1:1 with a supplement-free M200 medium, poured in 12-well plates, and allowed to solidify at 37 °C. Sub confluent HUtMECs were harvested and preincubated for 1 hour in growth supplement-free M200 medium in microcentrifuge tubes. An equal volume of M200 medium containing FGF2/EGF was added. In addition, conditioned medium from Gata2 f/f ;Gata3 f/f ;UBC Cre trophoblast stem cells cultured in the presence (control) and absence of tamoxifen (GATA DKO) were added. The cells were plated on Matrigel (1.5 × 105 cells/well) and incubated at 37 °C and photographed at different time intervals.
Quantitative RT-PCR
Total RNA from cells was extracted with the RNeasy Mini Kit (Qiagen). Samples isolated using FACS were further processed using the PicoPure RNA Isolation kit. cDNA samples were prepared and analyzed by qRT-PCR following procedures described earlier (78) .
Genotyping
Genomic DNA samples were prepared using tail tissues or embryonic tissues from the mice using the REDExtract-N-Amp Tissue PCR kit (Sigma-Aldrich). Genotyping was done using REDExtract-N-Amp PCR ReadyMix (Sigma-Aldrich) and respective primers. Respective primers are listed in the materials and methods section.
Immunofluorescence
For immunostaining with mouse tissues, slides containing cryosections were dried, fixed with 4% In situ hybridization E13.5 whole conceptus cryosections were subjected to staining using RNAscope 2.5 HD Detection Kit (ACD Bio, Newark, CA). RNAscope probe for Tpbpa was used to detect the junctional zone of the mouse placenta, while hematoxylin was used as the counterstain.
Statistical analyses
Independent data sets were analyzed by analysis of variance (ANOVA) using Student's t-test and are presented as mean±s.e. 
Primer List
Primers used for genotyping
Primers used for quantitative RT-PCR analysis
Figure legends
